ContraFect

YTD

ALL

Why Robinhood?

You can watch ContraFect and buy or sell other stocks, ETFs, and their options commission-free!

About CFRX

ContraFect Corp. is a clinical stage biotechnology company, which engages in the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. Its product pipeline consists of CF-301, Gram-Negative Lysins, and Amurin Peptides.

CEO

Michael Messinger, CPA

CEOMichael Messinger, CPA

Employees

—

Employees—

Headquarters

Yonkers, New York

HeadquartersYonkers, New York

Founded

2008

Founded2008

Employees

—

Employees—

CFRX Key Statistics

Market cap

1.10K

Market cap1.10K

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

3.00

Average volume3.00

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$0.14

52 Week high$0.14

52 Week low

—

52 Week low—

Stock Snapshot

The current ContraFect(CFRX) stock price is $2.24, with a market capitalization of 1.1K.

On 2026-07-20, ContraFect(CFRX) stock opened at —, reached a high of —, and a low of —.

ContraFect(CFRX) shares are trading with a volume of 0, against a daily average of 3.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.